Bondronat: Side Effects, Overdose and Pregnancy Information
Main ingredient in Bondronat tablets and injection is Ibandronic acid, which is a type of drug known as bisphosphonate. Bisphosphonate in Bondronat prevents the bone loss
by slowing down calcium loss from bones. Bondronat is used to treat osteoporosis in menopausal women. In these women Bondronat has been shown to reduce the risk of breaking a bone in the spine, but it is not known if Bondronat is effective at preventing hip fractures. Bondronat can also be used to prevent bone damage when Breast Cancer has spread to the bones.
BONDRONAT SIDE EFFECTS
Common Bondronat side effects may include allergic reactions such as skin rash or itching or hives,
black stools,
change in vision,
chest pain,
heartburn, stomach pain,
jaw pain, redness of the skin,
trouble swallowing , and swelling of the face, lips, throat or tongue.
Rare side effects of Bondronat may include
muscle or bone pain,
changes in taste,
diarrhea, constipation,
headache,
nausea, vomiting, and gas.
Bondronat Warning and Caution
Bondronat can cause irritation and ulceration of the esophagus.
Bondronat tablet should be taken on the same date each month, in the morning after an overnight fast of at least six hours. Bondronat should be swallowed whole with a glass of plain water (no mineral water) while you are sitting or standing in an upright position. Do not chew or suck the tablet. You should not lie down for one hour after taking your Bondronat tablet. You should not eat or drink anything other than plain water for one hour after taking Bondronat as food and some drinks (including mineral water) can interfere with the absorption of Bondronat therefore make it less effective.
Avoid taking any other drug by mouth in the six hours before you take your Bondronat tablet, at the same time as your Bondronat tablet, or in the hour after you have taken the tablet.
Upon experiencing any signs of problems with swallowing, pain on swallowing, pain behind your chest bone, or heartburn, stop taking Bondronat and inform your physician.
Bisphosphonates in Bondronat has been linked with a rare condition called osteonecrosis of the jaw. The majority of cases of this condition have been in cancer patients treated with bisphosphonates by injection into a vein and many of these patients were also having treatment with chemotherapy or corticosteroids. However, the condition has also been seen in people taking bisphosphonates by mouth. The risk may be increased by poor dental hygiene, dental problems, tooth extractions and dental surgery.
Bondronat should be used with caution in
decreased kidney function,
disorders of the thyroid glands, and
vitamin D deficiency.
Bondronat should not to be used in
low levels of calcium in the blood (hypocalcaemia),
women who are unable to stand or sit upright for at least one hour,
Bondronat and Pregnancy
Bondronat has not been studied in pregnant women; therefore its safety has not been established. Bondronat should not be used during pregnancy.
It is not known if Bondronat passes into breast milk. Nursing mothers should switch to bottle-feed while using Bondronat.
Bondronat Overdose
Bondronat overdose symptoms may include nausea, heartburn, stomach pain, diarrhea, muscle cramps, numbness or tingling, seizure, irritability, and unusual thoughts or behavior. In case of Bondronat Overdose seek medical attention right away.
If you forget to take your monthly Bondronat tablet, you should take it the morning after you remember, and then return to taking it once a month on your normal date. However, if you miss a dose of Bondronat but realize that your next dose is due in the next seven days, forget the missed dose and take your next scheduled dose on the day you would normally take it. You should not take two Bondronat tablets within the same week.
A-Z Drug List
